• Users Online: 555
  • Print this page
  • Email this page
Year : 2022  |  Volume : 19  |  Issue : 1  |  Page : 1-4

The interrelationship between diabetes mellitus and COVID-19

1 Department of Biology, College of Sciences, University of Babylon, Babylon, Iraq
2 Department of Medical Microbiology, College of Medicine, University of Babylon, Babylon, Iraq

Correspondence Address:
Zainab Adil Ghani Chabuck
Department of Medical Microbiology, College of Medicine, University of Babylon, Babylon
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/MJBL.MJBL_11_22

Rights and Permissions

The pandemic of coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 100 million individuals, including more than 2 million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in patients with COVID-19. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded81    
    Comments [Add]    

Recommend this journal